 |
 |

Antioxidant Supplements and Mortality
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: We have several concerns about the meta-analysis of randomized trials of antioxidant supplements by Dr Bjelakovic and colleagues.1 First, establishing causality requires considering temporal relationship, dose-response relationship, evidence of supplement use, effects that disappear after discontinuation of supplementation, lack of alternative explanations, and recurrence after restarting supplement use. It is difficult to establish a causal relationship between supplement use and risk of death when 2 of the criteria (response to rechallenge and response to discontinuation of use) cannot be applied to the outcome of death. Hence, greater reliance must be placed on plausible biological mechanisms and evidence that nutrients affect specific disorders. As the authors pointed out, it is likely that increased cancer and cardiovascular mortality are the main reasons for the increased all-cause mortality. The review would have been more convincing if it had also addressed cause-specific mortality.
Second, the exclusion of 405 studies with no . . . [Full Text of this Article]
Han-Yao Huang, PhD, MPH
han-yao_huang@merck.com
Steven Teutsch, MD, MPH
Outcomes Research and Management Merck & Co, Inc West Point, Pennsylvania
Eric Bass, MD, MPH
Department of Medicine Johns Hopkins School of Medicine Baltimore, Maryland
RELATED LETTERS
Antioxidant Supplements and Mortality
Demetrius Albanes
JAMA. 2007;298(4):400.
EXTRACT
| FULL TEXT
Antioxidant Supplements and Mortality
Harri Hemilä
JAMA. 2007;298(4):401.
EXTRACT
| FULL TEXT
Antioxidant Supplements and Mortality
Philip R. Taylor and Sanford Dawsey
JAMA. 2007;298(4):401-402.
EXTRACT
| FULL TEXT
Antioxidant Supplements and Mortality—Reply
Lise Lotte Gluud, Goran Bjelakovic, Dimitrinka Nikolova, Rosa G. Simonetti, and Christian Gluud
JAMA. 2007;298(4):402-403.
EXTRACT
| FULL TEXT
RELATED ARTICLES
Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary Prevention: Systematic Review and Meta-analysis
Goran Bjelakovic, Dimitrinka Nikolova, Lise Lotte Gluud, Rosa G. Simonetti, and Christian Gluud
JAMA. 2007;297(8):842-857.
ABSTRACT
| FULL TEXT
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Womens Health Study: A Randomized Controlled Trial
I-Min Lee, Nancy R. Cook, J. Michael Gaziano, David Gordon, Paul M Ridker, JoAnn E. Manson, Charles H. Hennekens, and Julie E. Buring
JAMA. 2005;294(1):56-65.
ABSTRACT
| FULL TEXT
|